不同佐剂灭活狂犬病疫苗的免疫原性、效力及转录组变化比较
本研究在ICR小鼠中比较两种铝佐剂与五种其他佐剂(BLPs、AS02、AS03、MF59和Poly I:C)增强狂犬病疫苗效力的能力,纳米铝佐剂诱导更早且更强的狂犬病毒中和抗体产生并在攻毒试验中提供更有效保护,转录组分析显示不同佐剂免疫后mRNA表达存在显著差异但两种铝佐剂疫苗诱导相似的基因表达。
要点
- 纳米铝佐剂较其他佐剂诱导更早且更强的狂犬病毒中和抗体。
- 纳米铝佐剂在攻毒试验中提供更有效的保护。
- 不同佐剂免疫后小鼠mRNA表达存在显著差异,但两种铝佐剂疫苗诱导相似的基因表达。
核心结论
- 佐剂可作为狂犬病疫苗接种的增强剂,纳米铝佐剂可能是开发更有效狂犬病疫苗的候选佐剂。
- 这些数据为理解佐剂增强免疫反应的机制提供了基础。
研究设计与样本
- 在ICR小鼠中进行免疫接种,比较两种铝佐剂和五种其他佐剂(BLPs、AS02、AS03、MF59和Poly I:C)增强狂犬病疫苗效力的能力。
- 选择四组小鼠的血样进行mRNA测序,鉴定差异表达基因并进行基因本体(GO)和京都基因与基因组百科全书(KEGG)分析。
主要发现
- 与其他佐剂相比,纳米铝佐剂诱导更早且更强的狂犬病毒中和抗体产生。
- 纳米铝佐剂在攻毒试验中促进更有效的保护。
- 不同佐剂免疫后小鼠mRNA表达存在显著差异,但两种铝佐剂疫苗诱导相似的基因表达。
- 富集分析数据表明佐剂在激活抗原加工、呈递和初始免疫相关通路方面更具优势。
关键数值与推荐
- 原文未报告具体中和抗体滴度、保护率、差异表达基因数目及富集分析P值等数值。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Adjuvants have been proven to be very effective in enhancement of immune response of many antigens. However, few studies involved head-to-head comparison of their potentials in inactive rabies virus vaccine. In this study, we investigated two types of aluminum adjuvants and five other adjuvants (BLPs, AS02, AS03, MF59 and Poly I:C) on their capacity in enhancing the efficacy of rabies vaccine. The differences in immunogenicity and potency of rabies vaccines with different adjuvants were evaluated by immunizations in ICR mice. Compared with other adjuvants, nano-sized aluminum induced earlier and more vigorous production of rabies virus neutralizing antibodies and facilitated a more effective protection in the challenge test. Based on these results, to comprehensively and systematically explore the role of adjuvants in rabies vaccine immunization, blood samples from four groups were chosen to perform mRNA sequencing. The differentially expressed genes (DEGs) of groups were identified, both gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were conducted for these DEGs. The results showed that there were significant differences in mRNA expression between the mice after immunization with different adjuvants, but the two aluminum adjuvant vaccines induced similar gene expression. Moreover, the data of enrichment analysis indicated that adjuvants were more advantageous in activating the pathways associated with antigen processing, presentation and initial immunity. These results revealed that adjuvants can be used as an enhancer in rabies vaccination, and nano-sized aluminum may be a candidate adjuvant for the development of more effective rabies vaccines. And these data also provide a basis for understanding the mechanisms underlying adjuvants enhancement of the immune response.
引用
- Shi W, Kou Y, Xiao J, et al. Comparison of immunogenicity, efficacy and transcriptome changes of inactivated rabies virus vaccine with different adjuvants. Vaccine. 2018. PMID: 30037417. doi:10.1016/j.vaccine.2018.07.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。